Compound Detail
CHEMBL5646839
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5646839 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | BNMQFQAUXLWHJH-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
316.4
MW (Da)
5.33
ALogP
3
HBA
0
HBD
17.8
PSA (Ų)
0.50
QED
1
Ro5 Violations
4
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 7.13
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Neutrophil CHEMBL5314326 | IC50 | 7.13 | 7.13 | 74.5 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Neutrophil | IC50 | = | 74.5 | nM | 7.13 | Inhibition of fMLF/CB-induced human Neutrophil activation assessed as reduction ... | 37918036 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 37918036 | 10.1016/j.ejmech.2023.115874 | Neutrophil | 4 |
Data from ChEMBL 36 via Core Engine